Evidence map›Paper›PMID 32131646›Full record

ArticleJournal of enzyme inhibition and medicinal chemistry2020

Combining carbonic anhydrase and thioredoxin reductase inhibitory motifs within a single molecule dramatically increases its cytotoxicity.

Mikhail Krasavin, Tatiana Sharonova, Vladimir Sharoyko, Daniil Zhukovsky, Stanislav Kalinin, Raivis Žalubovskis, Tatiana Tennikova, Claudiu T Supuran

Open access · goldAbstract read
In one paragraph

Article in Journal of enzyme inhibition and medicinal chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Carbonic Anhydrase Inhibitors in Oncology.Sub-cellular biochemistry · 2026
    Review
  4. Article
  5. 1,2,3-Benzoxathiazine-2,2-dioxides - effective inhibitors of human carbonic anhydrases.Journal of enzyme inhibition and medicinal chemistry · 2023
    Article
  6. Article
  7. Article
  8. Room Temperature Synthesis of Bioactive 1,2,4-Oxadiazoles.International journal of molecular sciences · 2023
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Thioredoxin-dependent system. Application of inhibitors.Journal of enzyme inhibition and medicinal chemistry · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Mikhail KrasavinSaint Petersburg State University, Saint Petersburg, Russian Federation.
Tatiana SharonovaSaint Petersburg State University, Saint Petersburg, Russian Federation.
Vladimir SharoykoSaint Petersburg State University, Saint Petersburg, Russian Federation.
Daniil ZhukovskySaint Petersburg State University, Saint Petersburg, Russian Federation.
Stanislav KalininSaint Petersburg State University, Saint Petersburg, Russian Federation.
Raivis ŽalubovskisLatvian Institute of Organic Synthesis, Riga, Latvia.
Tatiana TennikovaSaint Petersburg State University, Saint Petersburg, Russian Federation.
Claudiu T SupuranNeurofarba Department, Universita degli Studi di Firenze, Florence, Italy.ORCID http://orcid.org/0000-0003-4262-0323
St Petersburg University · RURiga Technical University · LVUniversity of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A hypothesis that simultaneous targeting cancer-related carbonic anhydrase

Indexed as

Antineoplastic AgentsCarbonic AnhydrasesCell Line, TumorCell ProliferationCell SurvivalDose-Response Relationship, DrugDrug Screening Assays, AntitumorEnzyme InhibitorsHumansMolecular StructureStructure-Activity RelationshipSulfonamidesThioredoxin-Disulfide ReductaseAntineoplastic AgentsCarbonic AnhydrasesEnzyme InhibitorsSulfonamidesThioredoxin-Disulfide ReductaseAnticancer agentscancer cell defence mechanismscarbonic anhydrase inhibitiondual pharmacophoreshypoxiaMichael acceptorsoxidative stresssynergistic effectthioredoxin reductase inhibitionzinc-binding group

Identifiers

PMID32131646
PMCPMC7067156
OpenAlexW3009269681

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.